ArticleJournal of enzyme inhibition and medicinal chemistry2022

6-Amino-2,4,5-trimethylpyridin-3-ol and 2-amino-4,6-dimethylpyrimidin-5-ol derivatives as selective fibroblast growth factor receptor 4 inhibitors: design, synthesis, molecular docking, and anti-hepatocellular carcinoma efficacy evaluation.

Chhabi Lal Chaudhary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.